| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Hospital & Healthcare Services
|
Compare with Industry peers |
| Website | http://www.krsnaadiagnostics.com | |
| Market Cap | 1,399.55 Cr. | |
| Enterprise Value(EV) | 1,257.48 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 19.47 | Trailing Twelve Months Ending 2022-12 |
| Price-Earning Ratio (PE) | 22.61 | Trailing Twelve Months Ending 2022-12 |
| Industry PE | 46.41 | Trailing Twelve Months Ending 2022-12 |
| Book Value / Share | 229.23 | Trailing Twelve Months Ending 2022-12 |
| Price to Book Value | 1.92 | Calculated using Price: 440.25 |
| Dividend Yield | 0.56 | Period Ending 2022-03 |
| No. of Shares Subscribed | 3.14 Cr. | 31,397,613 Shares |
| FaceValue | 5 | |
| Company Profile | ||
| Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging/radiology services (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres. | ||
| 1 Day |
|
-0.16% |
| 1 Week |
|
-2.33% |
| 1 Month |
|
+22.75% |
| 3 Month |
|
-3.70% |
| 6 Month |
|
-11.97% |
| 1 Year |
|
-10.04% |
| 2 Year |
|
|
| 5 Year |
|
|
| 10 Year |
|
| 1 years | 2022-03 | |
| Return on Equity (%) | 10.02 | |
| Return on Capital Employed (%) | 14.47 | |
| Return on Assets (%) | 7.81 |
| Particulars | 2 years | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 684 | 706 | |
| Non Curr. Liab. | 42 | 40 | |
| Curr. Liab. | 149 | 176 | |
| Minority Int. | |||
| Equity & Liab. | 875 | 922 | |
| Non Curr. Assets | 541 | 591 | |
| Curr. Assets | 334 | 332 | |
| Misc. Exp. not W/O | |||
| Total Assets | 875 | 922 |
| Particulars | 2 years | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
| Net Sales | 455 | 462 | |
| Other Income | 15 | 18 | |
| Total Income | 470 | 480 | |
| Total Expenditure | -324 | -346 | |
| PBIDT | 146 | 133 | |
| Interest | -18 | -7 | |
| Depreciation | -41 | -50 | |
| Taxation | -18 | -15 | |
| Exceptional Items | |||
| PAT | 68 | 61 | |
| Minority Interest | |||
| Share Associate | |||
| Other Related Items | |||
| Consolidated Net Profit | 68 | 61 | |
| Adjusted EPS | 22 | 19 |
| Particulars | 1 years | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 128 | |
| Cash Fr. Inv. | -241 | |
| Cash Fr. Finan. | 176 | |
| Net Change | 64 | |
| Cash & Cash Eqvt | 88 |
|
Sat, 25 Mar 2023
Board Meeting Outcome for Held On 25Th March 2023 Inter-Alia Approved The Formation Of Operations Committee (Non Statutory Committee). This is to inform you that the Board of Directors of the Company at its meeting held today which commencedat 02:30 p.m. and concluded at 06:35 p.m. inter-alia approved the formation of Operations Committee(NonStatutoryCommittee). |
|
Fri, 24 Mar 2023
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Tata Small Cap Fund & Tata India Equity Fund Multipartner SICAV |
|
Mon, 20 Mar 2023
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 ("SEBI LODR") this is to inform you that the Company has been qualified as a L1 Bidder with regards to tender in consortium with Telecommunications Consultants India Ltd. with the Tender Estimated Size of INR 450 Crores by the National Health Mission Rajasthan for providing "Laboratory Services under Free Diagnostics Initiative on HUB and SPOKE Model under NHM" in the entire State of Rajasthan. |
| Tue, 28 Mar 2023 |
Opening at Low
|
Closing Below Previous Low
|
High Increase in 1 Month
|
Closing Near 100 SMA
|
CCI Bearish
|
Equities
M.F.
Sectors